Evidence map›Paper›PMID 42560306›Full record

ReviewJournal of bacteriology2026

Pulcherriminic acid as an antibiofilm effector: expanding

Ramya Srinivasan, Tamil Selvam Saravanan, Soham Utpat, Moshe Shemesh, Satish Kumar Rajasekharan

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ramya SrinivasanDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
Tamil Selvam SaravananDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
Soham UtpatDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
Moshe ShemeshDepartment of Food Science, Institute of Postharvest Technology and Food Sciences, Agricultural Research Organization (ARO), Rishon LeZion, Israel.ORCID 0000-0002-3854-6151
Satish Kumar RajasekharanDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.ORCID 0000-0002-3470-5565

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic and persistent biofilms are a major challenge in medicine and industry, acting as resilient microbial communities that resist antibiotics and cause persistent infections. In this review, we discuss pulcherriminic acid, a promising iron-chelating molecule produced by antagonistic

Indexed as

Antifungal AgentsBacillus subtilisBiofilmsCandida albicansIronMetabolic EngineeringPyrazinesAntifungal AgentsIronpulcherriminic acidPyrazinesantagonisticBacillusantibiofilm agentsBiofilm dependent modulationbiofilm formationB. subtilisC. albicanspulcherriminic acid

Identifiers

PMID42560306
PMCPMC13584742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.